McKesson Appoints Bansi Nagji to Executive Vice President of Corporate Strategy and Business Development
McKesson Corporation (NYSE:MCK) today announced that Bansi Nagji has been appointed executive vice president of corporate strategy and business development. Starting this week, Nagji reports to chairman and CEO John Hammergren and he succeeds Brian Tyler, who has fully transitioned to a new position as president, North American Pharmaceutical Distribution and Services.
Bansi Nagji, Executive Vice President of Corporate Strategy and Business Development, McKesson Corporation (Photo: Business Wire)
“Bansi brings strong international strategy experience to the McKesson executive team, along with deep innovation, leadership and marketing expertise,” said John Hammergren, chairman and CEO, McKesson Corporation. “Bansi will be a tremendous asset to the company as we leverage our new global presence on behalf of our customers and partners. He will provide a valuable and unique perspective on the challenges and opportunities facing healthcare as reform drives further transformation throughout the industry.”
Nagji comes to McKesson from Deloitte Consulting, LLP, where he led their U.S. and global strategy practice. Prior to Deloitte, Bansi was president of Monitor Group, a global management consulting firm that was acquired by Deloitte in 2013. He was instrumental in the integration of Monitor into Deloitte’s operations.
Nagji has more than 20 years of experience working with clients on enterprise-wide growth and innovation challenges in the life sciences and consumer sectors. At Deloitte, he strengthened the company’s global reach as the leader of its Global Strategy service line and co-chair of the Global Strategy Governance Committee. A noted expert on innovation, he has authored several articles and papers on the topic. Nagji has previously served as on the Board of Directors of Deloitte, LLP and several other business and nonprofit boards.
Prior to joining Monitor, he worked as a solicitor in London with one of Europe’s largest law firms. He holds a BA and MA from Cambridge University, England, and an MBA with Distinction from INSEAD, France.
Brian Tyler Promoted to President, North American Pharmaceutical Distribution and Services
Tyler, McKesson’s former strategy chief, has fully transitioned to a new role that was created after McKesson’s acquisition of the global pharmaceutical distribution company, Celesio. Tyler, a longtime McKesson executive, is responsible for the company’s North American pharmaceutical distribution and related businesses, including McKesson U.S. Pharmaceutical, McKesson Canada, McKesson Specialty Health and McKesson Pharmacy Systems & Automation. Tyler reports to Paul Julian, executive vice president and group president.
“Brian is ideally suited to take on this newly established role, given his extensive experience with most of the businesses that fall under his new area of responsibility,” said Hammergren. “In conjunction with our Celesio leadership team, Brian will lead our efforts to maximize operational excellence and facilitate collaboration across our businesses to benefit our customers and business partners.”
An 18-year McKesson veteran, Tyler has served as president of McKesson U.S. Pharmaceutical, McKesson Medical-Surgical and McKesson Specialty Care Solutions.
About McKesson Corporation
McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit www.mckesson.com.
Sorry. No data so far.